NHL-Shield

NEW YORK -- Pittsburgh Penguins defenseman Caleb Jones has been suspended for 20 games, without pay, for violating the terms of the NHL/NHLPA Performance Enhancing Substances Program.

Under the terms of the Collective Bargaining Agreement, the suspension is accompanied by mandatory referral to the NHL/NHLPA Player Assistance Program for evaluation and possible treatment.

The National Hockey League will have no further comment on this matter.

STATEMENT FROM CALEB JONES

“I have been informed of my positive test result and suspension under the NHL/NHLPA Performance Enhancing Substances Program.

At the time of the test, I was receiving an exosome therapy for a documented injury from an outside provider. I believe that my positive test was related to a contaminated substance associated with that treatment. While I did not use the prohibited substance intentionally or for performance enhancement, I understand that players are responsible for everything that enters their body and accept the discipline imposed by the program. I’m sorry to have let down my teammates, the Penguins organization, and our fans.”

STATEMENT FROM PITTSBURGH PENGUINS

"Caleb Jones informed us this week that he tested positive for a performance enhancing substance under the NHL/NHLPA Performance Enhancing Substances Program.

"Throughout the process, Caleb has been forthcoming with the organization as to how he believes the positive test occurred. Caleb takes full responsibility for his actions, despite him being unaware that what he consumed was a prohibited substance at the time.

"The organization appreciates his transparency regarding this matter, and Caleb will follow all NHL and NHLPA protocols related to his suspension. Caleb has the full support of the Penguins organization, and we look forward to welcoming him back to the ice when he is cleared."